Zydus gets USFDA nod for generic version of anti-epilepsy drug
Eligible for 180 days shared exclusivity for Brivaracetam tablets.
Eligible for 180 days shared exclusivity for Brivaracetam tablets.
Drugmaker Zydus Lifesciences has received the United States Food and Drug Administration (USFDA)…